Gen-Probe’s Tigris system enables high-volume labs to process hundreds of molecular diagnostics tests in a single shift, with minimal hands-on work required of technicians. Bloomberg is reporting that Gen-Probe is putting itself up for sale.

Gen-Probe’s Tigris system enables high-volume labs to process hundreds of molecular diagnostics tests in a single shift, with minimal hands-on work required of technicians. Bloomberg is reporting that Gen-Probe is putting itself up for sale. Photo by Photo courtesy of Gen-Probe

GEN-PROBE INC.

President and CEO: Carl Hull.

Revenue: $543.3 million in 2010; $498.3 million in 2009.

Net income: $106.9 million in 2010; $91.8 million in 2009.

No. of local employees: 1,100.

Headquarters: San Diego, near Sorrento Mesa area.

Year founded: 1983.

Stock symbol and exchange: GPRO on Nasdaq.

Company description: Maker of molecular diagnostics products used in detecting diseases in humans and screening human blood as well as in biomedical research.

There are rumors swirling around that Gen-Probe Inc...

Take 1 minute to subscribe and you'll get this story immediately, plus:

Already a subscriber? Sign in

  • 52 weekly issues
  • Subscriber-only digital content every business day, plus full access to SDBJ.com archives
  • Book of Lists — the most comprehensive business resource in San Diego
  • San Diego 500 — influential business leaders you need to know
Yours for only $129